The role of BARD1 in limiting tumorigenesis has been highlighted in studies of neuroblastoma, where single nucleotide polymorphisms (SNPs), which increase full-length BARD1 mRNA (BARD1-FL) expression, hinder tumour progression [11]. The gene discussed is BARD1; the disease is neuroblastoma.